BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34181432)

  • 1. Automated Assignment of Proteoform Classification Levels.
    Rolfs Z; Smith LM
    J Proteome Res; 2021 Aug; 20(8):4101-4105. PubMed ID: 34181432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving Proteoform Identifications in Complex Systems Through Integration of Bottom-Up and Top-Down Data.
    Schaffer LV; Millikin RJ; Shortreed MR; Scalf M; Smith LM
    J Proteome Res; 2020 Aug; 19(8):3510-3517. PubMed ID: 32584579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteoform Analysis and Construction of Proteoform Families in Proteoform Suite.
    Schaffer LV; Shortreed MR; Smith LM
    Methods Mol Biol; 2022; 2500():67-81. PubMed ID: 35657588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of Human Proteoform Families from 21 Tesla Fourier Transform Ion Cyclotron Resonance Mass Spectrometry Top-Down Proteomic Data.
    Schaffer LV; Anderson LC; Butcher DS; Shortreed MR; Miller RM; Pavelec C; Smith LM
    J Proteome Res; 2021 Jan; 20(1):317-325. PubMed ID: 33074679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constructing Human Proteoform Families Using Intact-Mass and Top-Down Proteomics with a Multi-Protease Global Post-Translational Modification Discovery Database.
    Dai Y; Buxton KE; Schaffer LV; Miller RM; Millikin RJ; Scalf M; Frey BL; Shortreed MR; Smith LM
    J Proteome Res; 2019 Oct; 18(10):3671-3680. PubMed ID: 31479276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding Proteoform Identifications in Top-Down Proteomic Analyses by Constructing Proteoform Families.
    Schaffer LV; Shortreed MR; Cesnik AJ; Frey BL; Solntsev SK; Scalf M; Smith LM
    Anal Chem; 2018 Jan; 90(2):1325-1333. PubMed ID: 29227670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Proteoforms with Unknown Post-translational Modifications Using the MIScore.
    Kou Q; Zhu B; Wu S; Ansong C; Tolić N; Paša-Tolić L; Liu X
    J Proteome Res; 2016 Aug; 15(8):2422-32. PubMed ID: 27291504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Markov Chain Monte Carlo Method for Estimating the Statistical Significance of Proteoform Identifications by Top-Down Mass Spectrometry.
    Kou Q; Wang Z; Lubeckyj RA; Wu S; Sun L; Liu X
    J Proteome Res; 2019 Mar; 18(3):878-889. PubMed ID: 30638379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TopPIC: a software tool for top-down mass spectrometry-based proteoform identification and characterization.
    Kou Q; Xun L; Liu X
    Bioinformatics; 2016 Nov; 32(22):3495-3497. PubMed ID: 27423895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intact-Mass Analysis Facilitating the Identification of Large Human Heart Proteoforms.
    Schaffer LV; Tucholski T; Shortreed MR; Ge Y; Smith LM
    Anal Chem; 2019 Sep; 91(17):10937-10942. PubMed ID: 31393705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Evaluation of Protein Sequence Filtering Algorithms for Proteoform Identification Using Top-Down Mass Spectrometry.
    Kou Q; Wu S; Liu X
    Proteomics; 2018 Feb; 18(3-4):. PubMed ID: 29327814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mass graph-based approach for the identification of modified proteoforms using top-down tandem mass spectra.
    Kou Q; Wu S; Tolic N; Paša-Tolic L; Liu Y; Liu X
    Bioinformatics; 2017 May; 33(9):1309-1316. PubMed ID: 28453668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Quantification of Murine Mitochondrial Proteoforms Using an Integrated Top-Down and Intact-Mass Strategy.
    Schaffer LV; Rensvold JW; Shortreed MR; Cesnik AJ; Jochem A; Scalf M; Frey BL; Pagliarini DJ; Smith LM
    J Proteome Res; 2018 Oct; 17(10):3526-3536. PubMed ID: 30180576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine Counting via Isotopic Chemical Labeling for Intact Mass Proteoform Identifications in Tissue.
    Pavek JG; Frey BL; Frost DC; Gu TJ; Li L; Smith LM
    Anal Chem; 2023 Oct; 95(41):15245-15253. PubMed ID: 37791746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ProteoCombiner: integrating bottom-up with top-down proteomics data for improved proteoform assessment.
    Lima DB; Dupré M; Duchateau M; Gianetto QG; Rey M; Matondo M; Chamot-Rooke J
    Bioinformatics; 2021 Aug; 37(15):2206-2208. PubMed ID: 33165572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Top-Down Proteomics and the Challenges of True Proteoform Characterization.
    Po A; Eyers CE
    J Proteome Res; 2023 Dec; 22(12):3663-3675. PubMed ID: 37937372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Internal Fragment Ions Disambiguate and Increase Identifications in Top-Down Proteomics.
    Rolfs Z; Smith LM
    J Proteome Res; 2021 Dec; 20(12):5412-5418. PubMed ID: 34738820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput quantitative top-down proteomics.
    Cupp-Sutton KA; Wu S
    Mol Omics; 2020 Apr; 16(2):91-99. PubMed ID: 31932818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capillary Zone Electrophoresis-Tandem Mass Spectrometry with Activated Ion Electron Transfer Dissociation for Large-scale Top-down Proteomics.
    McCool EN; Lodge JM; Basharat AR; Liu X; Coon JJ; Sun L
    J Am Soc Mass Spectrom; 2019 Dec; 30(12):2470-2479. PubMed ID: 31073891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ProForma: A Standard Proteoform Notation.
    LeDuc RD; Schwämmle V; Shortreed MR; Cesnik AJ; Solntsev SK; Shaw JB; Martin MJ; Vizcaino JA; Alpi E; Danis P; Kelleher NL; Smith LM; Ge Y; Agar JN; Chamot-Rooke J; Loo JA; Pasa-Tolic L; Tsybin YO
    J Proteome Res; 2018 Mar; 17(3):1321-1325. PubMed ID: 29397739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.